Background and Aims: the prognosis for patients with ampulla of Vater cancer is better than other periampullary cancers. the aim of the present study is to determine the clinicopathologic factors predictive of survival and recurrence in patients with ampulla of Vater cancer.
INTRODUCTION
Ampulla of Vater cancer is a type of periampullary tumor with a better prognosis than other periampullary tumors (1) . Patients usually present with obstructive jaundice, therefore earlier detection can be done compared with other tumors (2) . Moreover, high resectability rates and less aggressive tumor characteristics have been the main factors related to longer survival (3, 4) . However, clinicopathological factors to predict tumor recurrence and survival after surgical resection of ampulla of Vater cancer are still controversial. The ampulla of Vater is a complex structure which is related to three distinct epithelial tissues: duodenum, bile duct, and pancreatic duct. Some investigators have tried to differentiate the origin of tumors into intestinal or pancreatobiliary subtypes to predict the prognosis (5, 6) . However, this is still difficult to differentiate, especially in large tumors.
Surgical options for ampulla of Vater cancer are pancreaticoduodenectomy (PD), pyloric-preserving PD (PPPD), and a local excision (transduodenal ampullectomy) (7, 8) . Some investigators have reported that endoscopic papillectomy in early stages of ampulla of Vater cancer is feasible and safe in well selected patients (9, 10) . Many clinicopathological variables have been reported to influence survival and recurrence following surgical resection for ampulla of Vater cancer. The objectives of this retrospective study were to evaluate the clinicopathological characteristics of ampulla of Vater cancer based on surgical experience during 18 years in a single institute. Survival outcome and recurrence pattern were investigated, and the clinicopathological predictors affecting survival and recurrence were also evaluated.
MATERIAL AND METHODS

PATIENT POPULATION
From January 1991 to December 2008, a total of 78 patients were explored for ampulla of Vater cancers at the Department of Surgery, Korea University Medical Center, Korea University Guro Hospital, Seoul, Korea. Of the 78 patients, 67 patients (85.9%) underwent R0 resection. Three patients (3.8%) underwent surgical resection for microscopic residual disease (R1), and eight patients (10.3%) underwent bypass surgery without resection (R2).
CLINICOPATHOLOGICAL INVESTIGATION
The following preoperative clinical information were retrospectively reviewed from the patients' records: age, sex, preoperative bilirubin levels, and fulfillment of preoperative biliary drainage, operative procedures, operative time, need for transfusion, postoperative complication, adjuvant therapy, mode of recurrence, and treatment modalities for recurrence. For postoperative complications, pancreatic fistula or pancreaticojejunostomy leakage was defined as drainage of amylase-rich fluid from intraoperatively placed closed suction drains after the fifth postoperative day. Delayed gastric emptying was defined as frequent vomiting and need for nasogastric decompression after oral intake was permitted.
Macroscopically, tumor number and diameter were evaluated. The gross morphological features were classified into two categories: non-infiltrative vs infiltrative and non-ulcerative vs ulcerative. The microscopic characteristics were investigated as follows: histologic type, differentiation, the presence of perineural invasion, duodenal invasion, pancreatic invasion, lymph node metastasis, and margin status. The histological analysis of margin status was performed along the duodenum, pancreatic, bile duct and retroperitoneal margin respectively. R0 describes a microscopically margin-negative resection in which no gross or microscopic residual tumor exists in the tumor bed. R1 indicates removal of all macroscopic diseases, but with microscopic margins that are positive for tumor. R2 indicates gross residual disease. Tumor stage was defined according to the pathological tumor node metastasis (pTNM) classification, proposed by the American Joint Committee on Cancer (11) . T1 tumors are limited to the ampulla of Vater or sphincter of Oddi, T2 tumors invade the duodenal wall, T3 tumors invade the pancreas, and T4 tumors invade peripancreatic soft tissues or other adjacent organs or structures.
Patients were followed up at 1-2 weeks after discharge and then every 3-6 months. Follow-up studies for ampulla of Vater cancer patients were laboratory tests including tumor markers (carcinoembryonic antigen, cancer antigen , and imaging studies such as abdominal ultrasonography and/or computed tomography (CT). Abdominal CT scan became a main diagnostic tool for detection of recurrence in more recent days. Follow-up tests were also carried out if disease recurrence was suspected when the patient visited the hospital due to symptoms such as pain, jaundice or vomiting and so on.
STATISTICAL ANALYSIS
Statistical calculations were performed using SPSS, version 13.0 for Windows (SPSS Inc. Chicago, Illinois, USA). Survival was measured from the date of surgery. Follow-up of patients was completed when death occurred or until the incised date of August 31, 2009. Disease-free survival was measured from the date of surgery to the date of recurrence detection. Survival was calculated by the Kaplan-Meier method. Clinicopathologic factors were analyzed by the univariate Kaplan-Meier method and compared by the logrank test to identify significant prognostic predictors for overall and disease-free survival. Multivariate analysis using the Cox proportional hazards model was performed to identify the independent prognostic predictors for overall and disease-free survival. Variables to be entered into the multivariate analysis were selected on the basis of the results of univariate analysis (P<0.1). A P value of < 0.05 was considered statistically significant.
RESULTS
CLINICAL CHARACTERISTICS
Of the 78 ampulla of Vater cancer patients, there were 43 men and 35 women, with a mean age of 61 years (range, 34~83 years). Six patients were diagnosed by medical check-up without symptoms. Chief complaints for hospital visits were as follows: abdominal pain in 26 patients, jaundice in 35 patients, dyspepsia in 8 patients, fever in 4 patients, and weight loss in 5 patients. Median value of total bilirubin at admission was 5.3mg/dl (range, 0.1~30.7 mg/dl). Preoperative biliary drainage was performed in 40 patients (51.3%), endoscopic nasobiliary drainage in 19 patients, endoscopic retrograde biliary drainage in 14 patients, and percutaneous transbiliary drainage in 7 patients.
R0 resections were achieved in 67 patients with a resectability rate of 86%. Pyloric-preserving pancreaticoduodenectomy (PPPD) was performed in 61 patients, classic pancreaticoduodenectomy (PD) in 7 patients, transduodenal ampullectomy in 3 patients, and bypass surgery (choledochojejunostomy or cholecystojejunostomy, gastrojejunostomy) in 7 patients. The method of pancreaticojejunostomy was duct to mucosa in 58 patients and the Dunking method in 8 patients. Pancreaticogastrostomy instead of pancreaticojejunostomy was performed in 2 patients. The reasons to perform palliative or noncurative surgery rather than curative R0 resection were as follows: locally advanced disease (n = 4), liver metastasis (n = 3), distant lymph node metastasis (n = 1), positive resection margin (n = 1), and poor general condition with liver cirrhosis (n = 1). The mean operative time was 370 minutes (range, 140~780 minutes). Intraoperative transfusions were required in 35 patients. Median hospital stay was 20 days (range, 10~101 days). The following operative morbidity occurred in 35 patients (45%) with 56 cases: pancreaticojejunostomy leakage with/without intraabdominal abscess (n = 25), delayed gastric emptying (n = 3), intraabdominal bleeding (n = 3), gastrointestinal bleeding (n = 2), panperitonitis due to bowel perforation (n = 2), wound complication (n = 13), chyle ascites (n = 1), stroke (n = 2), acute renal failure (n = 1), pulmonary complication (n = 1), portal vein thrombosis (n = 1), Steven-Johnson syndrome (n = 1), and Clostridium difficile colitis (n = 1). Two patients who underwent PD expired after operation (mortality rate of 2.6%). The underlying cause of death was an uncontrolled pancreaticojejunostomy leakage resulting in sepsis and multiorgan failure. Postoperative adjuvant chemotherapy was performed in 49 patients mainly using oral 5-fluoruracil.
PATHOLOGIC RESULTS
Pathologic results of the ampulla of Vater cancer were obtained in 70 patients who underwent R0 or R1 surgical resection in this study. All patients had a single tumor. The mean tumor size was 2.5 cm (0.5~6.0 cm). Tumor histology was identified as tubular adenocarcinoma in 64 patients, papillary in 3 patients, tubulopapillary in 1 patient, and mucinous in 2 patients. Tumors were well differentiated in 35 patients, moderately differentiated in 29 patients, and poorly differentiated in 6 patients. Perineural invasion was detected in seven patients (10%). T1 lesions were found in 12 patients (17.1%), T2 in 19 (27.2%), T3 in 22 (31.4%), and T4 in 17 (24.3%). Lymph node metastasis was present in 22 patients (31.4%). Median number of retrieved lymph nodes was 9.0 (3~37). Median number of metastatic lymph nodes in lymph node positive patients was 1 (1~6). According to AJCC TNM staging (11) Overall survival rates for 70 patients who underwent R0 and R1 resection were 68.9% at 3 years, 59.9% at 5 years, and 29.0% at 10 years (median survival time, 70 months).Overall survival rate for eight patients who underwent bypass surgery was 16.7% at 1 year (median survival time, 4 months) (R0,R1 vs R2, P < 0.001) (Fig. 1) . Seven patients survived more than 10 years. Most of them showed N0 disease and well differentiation tumor except one patient, respectively.
Univariate analysis of the clinicopathological predictors for overall survival revealed that total bilirubin greater than 5 mg/dl (P = 0.035), tumors demonstrating ulcerative lesions (P = 0.035), moderate to poor differentiation (P = 0.014), and pancreatic invasion (P = 0.042) were significantly poorer prognostic factors for overall survival. Patients who underwent preoperative biliary drainage demonstrated poorer survival than patients who had not, with marginal significance (P = 0.054). The presence of perineural invasion (P = 0.08), duodenal invasion (P = 0.556), T stage (P = 0.471), lymph node metastasis (P = 0.252), and stage (P = 0.124) did not affect overall survival ( Table 1 ). The 5-year survival rate of T1, T2, T3 and T4 tumors were 82.5%, 68.8%, 40.1%, and 58.3%, respectively. The 5-year survival rates of lymph node negative and positive patients were 63.5% and 50.8%, respectively. With regard to the number of metastatic lymph nodes, the 5-year survival rate for patients with less than three lymph nodes (n = 63) was not significantly different from that of patients with three or more metastatic lymph nodes (n = 7) (P = 0.172). The median number of retrieved lymph nodes in the patients with three or more metastatic lymph nodes was 15 (range from 7~25).
Multivariate analysis of the prognostic factors for overall survival using a Cox proportional hazards model demonstrates that pancreatic invasion (Hazard ratio [HR] = 2.226, confidence interval = 0.993~4.993) affects overall survival with marginal significance (P = 0.052) ( Table 2 ).
RECURRENCE AND PROGNOSTIC FACTORS FOR DISEASE-FREE SURVIVAL
Of the 70 patients who underwent R0 or R1 resection, recurrence occurred in 31 patients (44.3%). Overall disease-free survival rates were 62.8% at 3 years and 49.0% at 5 years. Thirteen patients demonstrated more than two recurrent sites at the initial detection of the recurrence. In one-third of the patients with Fig. 1 . Overall survival curve according to R status. Overall survival rates for 70 patients who underwent R0 and R1 resection were 59.9% at 5 years, and 29.0% at 10 years. Overall survival rate for eight patients who underwent bypass surgery was 16.7% at 1 year (R0, R1 vs R2, P < 0.001). recurrent tumors, recurrence occurred 3 years after operation. Patterns of recurrence were locoregional recurrence (n = 12), liver (n = 9), paraaortic or aortocaval lymph nodes (n = 9), supraclavicular lymph nodes (n = 2), retroperitoneal lymph nodes (n = 1), peritoneum (n = 6), lung (n = 4), bone (n = 3), and mediastinum (n = 1). Total bilirubin greater than 5mg/dl (P = 0.004), to perform preoperative biliary drainage (P = 0.009), moderate to poor differentiation (n = 0.001), and advanced stage (P = 0.002) were significant poorer predictors for disease-free survival. The presence of lymph node metastasis did not significantly affect disease-free survival (P = 0.086).
R0, R1
R2
However, disease-free survival was significantly better in patients with negative lymph node metastasis or 1 positive lymph node compared with those with ≥ 2 positive regional nodes (P = 0.022) (Fig. 2) . In the multivariate analysis, moderate to poor differentiation (P = 0.043, Hazard ratio = 2.306, confidence interval = 1.025-5.185) was an independently significant poorer prognostic factor for disease-free survival. The median survival time after detection of the recurrence was 10 months. Treatments of recurrent tumors were as follows: no treatment in 13 patients, chemotherapy in 12 patients, radiation therapy in 2 patients, and concurrent chemoradiation therapy in 4 patients.
Chemotherapy was driven systemically using a 5-flurouracil-, epirubicin-, cisplatin-, or gemcitabinebased regimen.
DISCUSSION
Ampulla of Vater cancers are one type of periampullary tumors demonstrating a more favorable prognosis than others. Higher resectability rate is closely related to the better prognosis (4, (12) (13) (14) . In the current study, estimated 5-and 10-year survival rate was 59.9% and 29.0%, respectively. The resectability rate (R0 resection) was 85.9%. In the review of literature the 5-and 10-year survival rates have been reported to be 38.2%~67.7% and 31.6%~53%, respectively (3, 4, 12, (14) (15) (16) (17) (18) (19) (20) (21) . The rate of potentially curative resection has been reported to be high up to 98% (3, 14, 16) . The prognostic factors for ampulla of Vater cancers following surgery have been reported to be jaundice (21, 22) , depth of tumor infiltration (3, 4, 22) , pancreatic invasion (3, 12, 15, 16, 21) , lymph node metastasis (3, 4, 14, 15, 22) , perineural invasion (3, 16, 18, 21) , tumor differentiation (14, 16) , and residual tumor status (16) . The routine use and duration of preoperative biliary drainage in jaundiced patients was controversial. In recent study, routine preoperative biliary drainage before surgery for pancreatic head cancer has been reported to increase the rate of complications (23). Patients with total bilirubin level greater than 5mg/ dl just before surgery demonstrated poorer survival in this study. This study was based on the retrospective data, thus preoperative treatment was not homogenous and the preoperative biliary drainage was not performed routinely. However, preoperative biliary drainage was performed more frequently in jaundiced patients. Some authors have reported that jaundice at presentation was associated with poorer survival (21, 22) . Jaundice at presentation may reflect a more advanced disease and may indicate a poorer prognosis for the patient (21) .
The presence of pancreatic invasion represents pT3 in AJCC TNM stage (11) . Patients without pancreatic invasion had significantly longer survival than those with pancreatic invasion (4), which is consistent with current studies. Harada et al. reported that regional lymph node metastasis was observed in only 19% of patients without pancreatic invasion, whereas it was observed in 62% of those with pancreatic invasion (24) . They suggested that pancreatic invasion indirectly indicates the presence of regional lymph node metastasis. Some investigators have recommended further resection including extended lymph node dis- section for patients with pancreatic invasion to improve the prognosis (12, 24) . Lymph node metastasis has been reported to be an important prognostic factor (3, 4, 14-16, 21, 22) . The frequency of lymph node metastasis was 38%~70% of the patients with ampulla of Vater cancers in the review of literature (14-16, 18, 21) . In light of the number of metastatic lymph nodes, de Castro et al. reported that patients with one lymph node metastasis demonstrated significantly better survival (5-year survival rate; 40%) than patients with metastasis to two or more lymph nodes (5-year survival rate; 0%) (25) . Roder et al. reported that patients with up to two positive lymph nodes have a more favorable prognosis than other patients (26) . Sakata et al. reported that survival outcome was significantly worsened in the following order: patients with negative lymph node metastasis, patients with 1-3 metastatic lymph nodes, and patients with ≥ 4 metastatic regional nodes (16) . Large tumor size (14, 26) , pancreatic invasion (5, 24) , ulcer formation and tumor differentiation (15), higher recurrent rate of liver metastasis following surgery (15) were significantly correlated with lymph node metastasis. The patients who had lymph node metastasis did not demonstrate significantly poorer survival in our study. This can be explained that this study had a relatively small number of patients who had metastatic lymph nodes. Six of seven patients who survived more than 10 years had N0 disease in the current study. Other authors have reported that lymph node metastasis was a significant factor for survival, however, there is no correlation between the number of metastatic lymph nodes and survival in patients with metastatic lymph nodes (19) . Duffy et al. reported that lymph node metastasis did not significantly affect overall survival, although lymph node negative patients demonstrated better survival, which is similar to our results (18) . Although the prognosis of extensive lymph node metastasis was dismal, Shirai et al. reported that the application of radical lymph node dissection appears to be justified in patients with lymph node metastasis (27) The frequency of recurrence after surgical resection of ampulla of Vater cancer has been 38%~42.5% (17, 22) . In this study, locoregional recurrence, liver and paraaortic or aortocaval lymph node metastasis were common patterns of recurrence. In other studies, the liver was found to be the most frequent site of recurrence followed by locoregional recurrence (17, 22) . Kayahara et al. reported that all patients with recurrence had retroperitoneal and nodal recurrence. Therefore, it is necessary for patients with ampulla of Vater cancer to undergo a systematic lymph node dissection including the lymph nodes around the superior mesenteric artery (28) . On the other hand, para-aortic lymph node dissection may enhance locoregional control in advanced tumors. However, the significance of para-aortic lymph node dissection remains unclear (27) . Lymph node metastasis was a statistically significant factor for recurrence (17, 28) . In our study, patients with two or more metastatic lymph nodes demonstrated significantly poorer disease-free survival than 0 or 1 metastatic lymph nodes.
In this study, one-third of the patients with recurrence (10 of 31 patients) had tumor recurrence detected more than 3 years after operation. Five patients demonstrated tumor recurrence more than 5 years after resection. Similarly, in another series, late recurrence (more than 3 (or 5) years after resection), was not rare in ampulla of Vater cancers (16, 29, 30) . Therefore, long-term follow up might be necessary for 5-year survivors.
There are several limitations in this study. The number of patients was relatively small to conclude the impact of lymph node metastasis on survival and recurrence. The proportion of the patients with metastatic lymph nodes and perineural invasion was low. However, this may suggest that ampulla of Vater cancers do not show aggressive tumor characteristics which are shown in other pancreatobiliary cancers. The extent of lymph node dissection was somewhat different according to extent of disease in the current study. However, almost all surgical resections were performed by a single experienced surgeon. Therefore, the same surgical strategy was applied in this study population.
In conclusion, pancreaticoduodenectomy for ampulla of Vater cancer resulted in a high rate of curative resection. Total bilirubin greater than 5mg/dl, ulcerative lesion, tumor differentiation, and the presence of pancreatic invasion were significant prognostic factors for overall survival. However, the presence of lymph node metastasis and the number of metastatic lymph nodes did not significantly affect overall survival in this study. Total bilirubin greater than 5mg/dl, tumor differentiation, and stage were significant prognostic predictors for disease-free survival. Disease-free survival was significantly better in patients with negative lymph node metastasis or 1 positive lymph node compared with those with ≥2 positive regional nodes. Survival after recurrence was poor. Aggressive surgical management that includes lymph node dissection for ampulla of Vater cancer might control lymph node spread, and eventually enhance overall survival.
